Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Dutch study links gene with pre-eclampsia:

This article was originally published in Clinica

Executive Summary

The risk of pre-eclampsia in pregnant women could be higher if a gene responsible for producing an enzyme that clears toxic compounds in the body is defective. That is the finding of a Dutch study (Journal of Medical Genetics, April 2001), which found that women with a history of the condition were almost twice as likely to carry a defect in the exon 3 section of the epoxide hydrolase gene as were healthy women, with three out of 10 of them affected. Only one in six healthy women had this defect, report Eric Steegers of the University Hospital Nijmegen, the Netherlands, and colleagues.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts